Loading…
Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
82pct
70d open
vs 5,821 other HR bills in the 113th — cohort avg 49d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (21)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2014 · fourth_quarter · Pharmacy
Issues related to prescription drug abuse, pharmacist provider status, drug pricing and drug supply chain safety.HR 3204 Drug Quality and Security Act HR 4069-Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S 2862-Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014 HR 4190-Medicare Patient Access to Pharmacist Services in Medically Underserved Communities HR 4437- Generic Drug Pricing Fairness Act of 2014 HR 4709-Ensuring Patient Access and Effective Drug Enforcement Acot of 2013 S. 1493-Medicare Efficient Drug Dispensing Act of 2013
Client expense: $3,810,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Substance Abuse & Mental Health Services Administration (SAMHSA)
2014 · second_quarter · Health Issues
HR 487, Primary Care Workforce Access Improvement Act, Urge House to cosponsor bill that would create GME pilot project to train primary care doctors, urge Senate offices to sponsor bill, GME reform increase primary care physician training, Pilot test alternatives to GME payment in order to increase primary care physician training.HR 2415, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. HR 3306, Telehealth Enhancement Act, Defining the home base for telehealth reimbursement to incluse family medicine offices. HR 4299, Improving Regulatory Transparency for New Medical Therapies Act, Improving DEA's process for scheduling new drugs approved by the FDA. HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act, Allowing supply chain stakeholders for prescription drugs to collaborate. HR 4810, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside. S. 1184, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. S. 1759, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program. S. 1994, TRICARE Moms Improvement Act, Supporting TRICARE payment for breastfeeding support and supplies and counseling. S. 1978, Increasing Primary Care Access Act, Family physician workforce, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program, increase family physician workforce. S. 2229, Expanding Primary Care Access and Workforce Act, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC, Reauthorizing Teaching Health Center GME program, Teaching Health Centers Graduate Medical Education, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC. S. 2450, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside No Bill Number, Extend Medicare/Medicare parity for primary care services, Extend Medicaid pay increase to Medicare levels beyond 2015. H. Con. Res. 96, House Budget Resolution, Protecting access to primary care in Medicaid. No Bill Number, Children's Health, Advocate for reauthorization of CHIP and children's mental health issues via coalition group meetings. No Bill Number, First Friday & Health Care Provider Meetings, Provider outreach groups for ACA, provider, and open enrollment issues. No Bill Number, SGR Repeal and Replacement process, Advocate for SGR repeal and new physician payment system that pays for value and primary care. No Bill Number, Medicaid Primary Care Bonus, Advocate for extension of the Medicaid bonus which expires at the end of 2014; advocate for members to mention at E&C hearing. No Bill Number, Medicare Primary Care Incentive Payment, Urge Ways and Means members to discuss at annual MedPac hearing. No Bill Number, Telemedicine,advocate for AAFP policies to be included in a potential bipartisan telehealth bill. No Bill Number, Teaching Health Centers, advocate for introduction of bipartisan bill to reauthorize the program. No Bill Number, FY funding increses in AHRQ, Title VII 747, NHSC, Teaching Health Center planning grants, Federal spending priorities to support workforce, research. No Bill Number, Veterans Health Care, advocate for inclusion of policies in final bill that allow family doctors to easily contract with the VA; advocate for primary-care GME slots in the VA. No Bill Number, FDA regulation of tobacco products, Oppose any limits or amendments that would limit FDA ability to regulate cigars. No Bill Number, E-Cigarettes impact on public health; Support FDA regulation of e-cigarettes, still urging FDA to regulate all tobacco. No Bill Number, National Health Service Corps trust fund reauthorization, appropriation, NHSC provides scholarships & debt relief as well as physicians for underserved communities.No Bill Number, Rural workforce, Comments on FQHC final rule. No Bill Number, VA committee on Woman Veterans, Nominated to FPs to the VA committee. No Bill Number, HHS Appropriations, Funding for health professions training grants, AHRQ research, and National Health Service Corps (NHSC). No Bill Number, Enhanced Medicaid payment for primary care, Extending the enhanced Medicaid payment for primary care. No Bill Number, Site-neutral payment for medical services, Support site-neutral payment by CMS for medical services. No Bill Number, White House's Health Kids and Save Sports Concussion Summit, Providing family physicians with latest information about sports concussions. No Bill Number, Veterans Health Administration, Allowing community physicians to charge VA for services to Vets. No Bill Number, Direct Primary Care, Primary care model of retainer-based practice. No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, 2014 conversion factor. No Bill Number, Graduate Medical Education, comments on 2015 proposed IPPS. No Bill Number, Health IT, asking CMS to delay MU2. No Bill Number, Non-discrimination, Advocate for correct use of non-discrimination clause in Affordable Care Act. No Bill Number, Extend Medicare/Medicare parity for primary services, extend Medicaid pay increase to Medicare levels beyond 2015. No Bill Number, First Fridays Meetings, Provider outreach group for Affordable Care Act, provider and open enrollment issues.
2014 · fourth_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: $338,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
S. 2862 - "Regulatory Transparency, Patient Access and Effective Drug Enforement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.H.R. 4709 - the "Ensuring Patient Access and Effective Drug Enforcement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.
Client expense: $940,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| WI |
| George Holding | Republican | NC |
| Judy Chu | Democratic | CA |
| Lamar Smith | Republican | TX |
| Mark E. Amodei | Republican | NV |
| Marsha Blackburn | Republican | TN |
| Peter Welch | Democratic | VT |
| Robert E. Latta | Republican | OH |
| Tim Griffin | Republican | AR |
Client expense: $627,558 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · fourth_quarter · Pharmacy
Issues related to pharmacy benefit managers, Sustainable Growth Rate, H.R. 1024, Medication Therapy Management Act of 2013; S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014, and H.R. 4709, the Ensuring Patient Access and Effective Drug Enforcement Act of 2014; and H.R. 4190, a bill to amend the Social Security Act to recognize pharmacies as providers under Medicare Part B.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act; S. 2862-The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; Implementation of P.L. 113 - 54 (Drug Quality and Security Act)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Alcohol and Drug Abuse
H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014 S. 2529 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014 S. 2862 - Regulatory Transparency, Patient Access and Effective Drug Enforcement Act of 2014
Client expense: $460,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Pharmacy
**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621)
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Medicare/Medicaid
Implementation of the Patient Protection and Affordable Care Act; issues related to Medicare drug reimbursement; H.R. 8; H.R. 800; S. 806; H.R.1416; H.R. 4709
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
General monitoring of issues related to transporting pharmaceuticals H.R. 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
Client expense: $3,850,760 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Health Issues
H.R. 3742, Antibiotic Development to Advance Patient Treatment Act: Provisions related to antibiotics and drug approval H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act: Provisions related to the Controlled Substances Act, Drug Enforcement Agency (DEA) regulation and related issues (a reintroduced version of H.R. 4069) H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act: Provisions related to DEA scheduling H.R. 5214, To require the Secretary of Health and Human Services to provide for recommendations for the development and use of clinical data registries for the improvement of patient care H.R. 5657, Fair Access for Safe and Timely (FAST) Generics Act: Provisions related to Risk Evaluation and Mitigation Strategies (REMS) H.R. 5805, Andrea Sloan Compassionate Use Reform and Enhancement Act: Provisions related to expanded access and compassionate use S. 1723, No ObamaCare Kickbacks Act of 2013: Provisions related to application of the anti-kickback statute to qualified health plans S. 2295, Patient Safety and Generic Labeling Improvement Act: Provisions related to drug safety labeling (112th Congress) S. 2917, Adding Ebola to the FDA Priority Review Voucher Program: Provisions related to new proposed voucher program; Public Law No. 113-233 Implementation issues related to the Food and Drug Administration Safety and Innovation Act (Public Law 112-144), including user fee reauthorization and FDA reform Implementation issues related to the Drug Quality and Security Act (Public Law 113-54), including pharmacy compounding and supply chain issues Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including health insurance exchanges Branded Prescription Drug Fee policy issues (79 Fed. Reg. 43631 (July 28, 2014)) 21st Century Cures legislation and policy issues R&D tax credit renewal as part of H.R. 5771, Tax Increase Prevention Act of 2014 Draft legislation relating to prescription drug coverage issues Issues related to value and cost of prescription drugs Issues related to user fee reauthorization and FDA reform Patient savings program policy issues Comparative effectiveness policy issues Academic detailing policy issues General HHS, NIH, and FDA related advocacy Biopharmaceutical innovation policy issues Prescription drug abuse policy issues FDA expedited drug approval policy issues Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products [Docket No. FDA-2013-N-0500]: Patient labeling Issues relating to communications about prescription drugs 340B program policy issues Importation policy issues Clinical trial policy issues
Client expense: $3,960,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Medicare Payment Advisory Commission (MedPAC), Patent & Trademark Office (PTO), SENATE, Treasury, Dept of, U.S. Trade Representative (USTR)
2014 · fourth_quarter · Pharmacy
H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services
Client expense: $570,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · fourth_quarter · Pharmacy
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014; S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..3979 Carl Levin and Howard P. Buck Mckeon National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Prescription Drug Abuse and Diversion; H.R. Res. 130-FY 2015 Continuing Resolution (though December 14, 2014); H.J. Res. 291- Making Further Continuing Appropriations for Fiscal Year 2015, And For Other Purposes (Until December 17, 2014); H.R.83 - FY2015 Omnibus; Consolidated and Further Continuing Appropriations Act; H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014;
Client expense: $420,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Office of Management & Budget (OMB), Office of Personnel Management (OPM), SENATE
2014 · fourth_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse, (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621); Counterfeit Drugs; Importation of Prescription Drugs
Client expense: $257,000 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · fourth_quarter · Health Issues
- PL 111-148 Patient Protection and Affordable Care Act Regulation: reposting requirements; benefits and payment parameters/reinsurance; 30 hr. full-time definition; excise tax - HR 3204 Drug Quality and Security Act regarding 3PL licensing and serialization standards - HR 2253 Health Care Fairness and Stability Act re: temporary delayed collection of the transitional reinsurance program payments- HR 3489 To amend Section 1341 of the PPACA to repeal the funding mechanism for the transitional reinsurance program in the individual market, and for other purposes: repeal funding source for the transitional reinsurance program - HR 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2014 to provide the opportunity for wholesalers or dispensers to remedy a situation before DEA closes a facility to ensure patients access to meds - HR 5644/S.2689 "Medicare Continuous Glucose Monitoring Access Act of 2014" to seek Medicaid reimbursement for seniors to obtain continuous glucose monitoring devices.
Client expense: $1,751,027 · Firm income: Not reported
Government targets: Defense Contract Audit Agency (DCAA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Internal Revenue Service (IRS), Labor, Dept of (DOL), Pension Benefit Guaranty Corporation (PBGC), Postal Rate Commission, SENATE, State, Dept of (DOS), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2014 · fourth_quarter · Health Issues
H.R. 4709/S. 2862: Ensuring Patient Access and Effective Drug Enforcement Act, and other legislative efforts to prevent prescription drug abuse.
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Alcohol and Drug Abuse
S. 2862 - "Regulatory Transparency, Patient Access and Effective Drug Enforement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.H.R. 4709 - the "Ensuring Patient Access and Effective Drug Enforcement Act of 2014," all provisions related to changes to the registration process under the Controlled Substances Act and the report to Congress on the effects of law enforcement activities on patient access to medications.
Client expense: $890,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: $240,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014" S.2862 "Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014"
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Health Issues
H.R. 3742, Antibiotic Development to Advance Patient Treatment Act: Provisions related to antibiotics and drug approval H.R. 4709, Ensuring Patient Access and Effective Drug Enforcement Act: Provisions related to the Controlled Substances Act, Drug Enforcement Agency (DEA) regulation and related issues (a reintroduced version of H.R. 4069) H.R. 4299, Improving Regulatory Transparency for New Medical Therapies Act: Provisions related to DEA scheduling H.R. 5214, To require the Secretary of Health and Human Services to provide for recommendations for the development and use of clinical data registries for the improvement of patient care H.R. 5657, Fair Access for Safe and Timely (FAST) Generics Act: Provisions related to DEA scheduling S. 1723, No ObamaCare Kickbacks Act of 2013: Provisions related to application of the anti-kickback statute to qualified health plans S. 2295, Patient Safety and Generic Labeling Improvement Act: Provisions relating to drug safety labeling (112th Congress) Implementation issues related to the Food and Drug Administration Safety and Innovation Act (Public Law 112-144), including user fee reauthorization and FDA reform Implementation issues related to the Drug Quality and Security Act (Public Law 113-54), including pharmacy compounding and supply chain issues Implementation issues related to the Patient Protection and Affordable Care Act (PPACA) (Public Law 111-148), including PPACA; Standards Related to Essential Health Benefits, Actuarial Value, and Accreditation rulemaking 21st Century Cures legislation and policy issues Draft legislation relating to prescription drug coverage issues Issues related to value and cost of prescription drugs Issues related to user fee reauthorization and FDA reform Patient savings program policy issues Comparative effectiveness policy issues Academic detailing policy issues General HHS, NIH, and FDA related advocacy Biopharmaceutical innovation policy issues Prescription drug abuse policy issues FDA accelerated approval policy issues Unapproved use policy issues 340B policy issues Importation policy issues Clinical trial policy issues
Client expense: $3,680,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Medicare Payment Advisory Commission (MedPAC), Patent & Trademark Office (PTO), SENATE, U.S. Trade Representative (USTR)
2014 · third_quarter · Pharmacy
H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts.H.R.4709, S.1277, S.1657, H.R.3392, H.R.4096 & S. 2862 legislation to prevent and reduce prescription drug abuse. H.R. 4190, Provide for coverage under Medicare program of pharmicist services
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Efforts to prevent prescription drug abuse, H.R. 4709- The Ensuring Patient Access to Effective Drug Enforcement Act of 2014
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Medicare/Medicaid
Implementation of the Patient Protection and Affordable Care Act; issues related to Medicare drug reimbursement; H.R. 8; H.R. 800; S. 806; H.R.1416; H.R. 4709
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
- PL 111-148 Patient Protection and Affordable Care Act Regulation: reposting requirements; benefits and payment parameters/reinsurance; 30 hr. full-time definition; excise tax - HR 3204 Drug Quality and Security Act regarding 3PL licensing and serialization standards - HR 2253 Health Care Fairness and Stability Act re: temporary delayed collection of the transitional reinsurance program payments- HR 3489 To amend Section 1341 of the PPACA to repeal the funding mechanism for the transitional reinsurance program in the individual market, and for other purposes: repeal funding source for the transitional reinsurance program - HR 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2014 to provide the opportunity for wholesalers or dispensers to remedy a situation before DEA closes a facility to ensure patients access to meds - HR 5644/S.2689 "Medicare Continuous Glucose Monitoring Access Act of 2014" to seek Medicaid reimbursement for seniors to obtain continuous glucose monitoring devices.
Client expense: $1,444,773 · Firm income: Not reported
Government targets: Defense Contract Audit Agency (DCAA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), Postal Rate Commission, SENATE, State, Dept of (DOS), Transportation Security Administration (TSA), Treasury, Dept of, U.S. Trade Representative (USTR), Veterans Affairs, Dept of (VA), White House Office
2014 · third_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)
Client expense: $361,413 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Alcohol and Drug Abuse
H.R. 4069 - Ensuring Patient Access and Effective Drug Enforcement Act of 2013 H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act of 2014 S. 2529 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2014
Client expense: $480,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Pharmacy
Rx Pedigree (Public Law 113-54); Prescription Drug Monitoring Programs; Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862); Hydrocodone Rescheduling (H.R. 1285, S. 621); Dextromethorphan (S. 644); Drug Shortages - Gray Market (H.R. 1958); Counterfeit Drugs; Importation of Prescription Drugs (H.R. 3715, S. 2549)
Client expense: $361,413 · Firm income: Not reported
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · third_quarter · Medicare/Medicaid
Social Security Act, Pharmacists Provider Status (HR 4190, amends Section 1861 of SSA) Controlled Substances Act, discussion regarding impact on long term care (HR 4709)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
Social Security Act, Pharmacists Provider Status (HR 4190, amends Section 1861 of SSA) Controlled Substances Act, discussion regarding impact on long term care (HR 4709)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
Social Security Act, Pharmacists Provider Status (HR 4190, amends Section 1861 of SSA) Controlled Substances Act, discussion regarding impact on long term care (HR 4709)
Client expense: $10,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
**see addendum pageImportation of prescription drugs (H.R. 3715, S. 2549) Drug Shortages and Gray Market (H.R. 1958) Rx Pedigree (PL 113-54) Prescription Drug Monitoring Programs Counterfeit Drugs Prescription Drug Abuse - General issues related to Rx drug abuse (S. 348, S. 1277, H.R. 4069, H.R. 4709, S. 2862), Hydrocodone Rescheduling (H.R. 1285, S. 621), Dextromethorphan (S. 644)
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 4709/S. 2862: Ensuring Patient Access and Effective Drug Enforcement Act, and other legislative efforts to prevent prescription drug abuse.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Pharmacy
H.R. 4709 - Ensuring Patient Access and Effective Drug Enforcement Act; S. 2862-The Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4299 - Improving Regulatory Transparency for New Medical Therapies Act; Implementation of P.L. 113 - 54 (Drug Quality and Security Act)
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
General monitoring of issues related to transporting pharmaceuticals H.R. 4709 Ensuring Patient Access and Effective Drug Enforcement Act of 2013 S. 2862, the Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014
Client expense: $3,101,780 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · third_quarter · Health Issues
H.R. 1285- To Amend the Controlled Substance Act to Make Any Substance Containing Hydrocodone a Schedule II Drug; S.621- The Safe Prescribing Act of 2013; H.R. 1024- The Medication Therapy Management Empowerment Act of 2013; S. 557 Medication Therapy Empowerment Act of 2013; H.R. 1188- The Preserving Our Hometown Independent Pharmacies Act of 2013; CMS proposed and final rule on Medicare Part D; H.R. 4709- Ensuring Patient Access and Effective Drug Enforcement Act of 2014;S.2862 - Regulatory Transparency, Patient Access, and Effective Drug Enforcement Act of 2014; H.R. 4190- To Amend Title XVIII of the Social Security Act to provide for coverage under the Medicare program of pharmacist services; FDAs action on and enforcement of Public Law No: 113-54; H.R.4577 - Ensuring Seniors Access to Local Pharmacies Act of 2014; H.R.4437 - Generic Drug Pricing Fairness Act; S. 1493 - Medicare Efficient Drug Dispensing Act of 2013; Generic Drug Pricing Spikes; The SGR Repeal and Medicare Beneficiary Access Improvement Act of 2013; H.R..4435 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); S. 2410 National Defense Authorization Act for Fiscal Year 2015 (Tricare Provisions); Perscription Drug Abuse and Diversion; H.Con.Res 25: Establishing the budget for the United States government for Fiscal Year 2014 and setting forth appropriate budgetary levels for Fiscal Year 2015 through 2023; S.Con.Res 8: An original concurrent resolution setting forth the Congressional budget for the United States Government for Fiscal Year 2014, revising the appropriate budgetary levels for Fiscal year 2013, and setting forth the appropriate budgetary levels for Fiscal Years 2015 through 2023.
Client expense: $530,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE
2014 · third_quarter · Health Issues
pharmaceutical and health care product distribution issues, Medicare Part B and D issues, Medicaid pharmacy issues, HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014.
Client expense: Not reported · Firm income: $15,000
2014 · third_quarter · Pharmacy
HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Client expense: Not reported · Firm income: $15,000
2014 · third_quarter · Pharmacy
HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Client expense: Not reported · Firm income: $7,500
2014 · third_quarter · Health Issues
pharmaceutical and health care product distribution issues, Medicare Part B and D issues, Medicaid pharmacy issues, HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014.
Client expense: Not reported · Firm income: $7,500
2014 · third_quarter · Health Issues
H.R. 4709: Ensuring Patient Access and Effective Drug Enforcement Act, and other legislative efforts to prevent prescription drug abuse.
Client expense: Not reported · Firm income: Not reported
2014 · third_quarter · Health Issues
Efforts to prevent prescription drug abuse. H.R. 4709: Ensuring Patient Access and Effective Drug Enforcement Act of 2014.
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014"
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Health Issues
HR 487, Primary Care Workforce Access Improvement Act, Urge House to cosponsor bill that would create GME pilot project to train primary care doctors, urge Senate offices to sponsor bill, GME reform increase primary care physician training, Pilot test alternatives to GME payment in order to increase primary care physician training.HR 2415, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. HR 3306, Telehealth Enhancement Act, Defining the home base for telehealth reimbursement to incluse family medicine offices. HR 4299, Improving Regulatory Transparency for New Medical Therapies Act, Improving DEA's process for scheduling new drugs approved by the FDA. HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act, Allowing supply chain stakeholders for prescription drugs to collaborate. HR 4810, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside. S. 1184, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. S. 1759, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program. S. 1994, TRICARE Moms Improvement Act, Supporting TRICARE payment for breastfeeding support and supplies and counseling. S. 1978, Increasing Primary Care Access Act, Family physician workforce, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program, increase family physician workforce. S. 2229, Expanding Primary Care Access and Workforce Act, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC, Reauthorizing Teaching Health Center GME program, Teaching Health Centers Graduate Medical Education, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC. S. 2450, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside No Bill Number, Extend Medicare/Medicare parity for primary care services, Extend Medicaid pay increase to Medicare levels beyond 2015. H. Con. Res. 96, House Budget Resolution, Protecting access to primary care in Medicaid. No Bill Number, Children's Health, Advocate for reauthorization of CHIP and children's mental health issues via coalition group meetings. No Bill Number, First Friday & Health Care Provider Meetings, Provider outreach groups for ACA, provider, and open enrollment issues. No Bill Number, SGR Repeal and Replacement process, Advocate for SGR repeal and new physician payment system that pays for value and primary care. No Bill Number, Medicaid Primary Care Bonus, Advocate for extension of the Medicaid bonus which expires at the end of 2014; advocate for members to mention at E&C hearing. No Bill Number, Medicare Primary Care Incentive Payment, Urge Ways and Means members to discuss at annual MedPac hearing. No Bill Number, Telemedicine,advocate for AAFP policies to be included in a potential bipartisan telehealth bill. No Bill Number, Teaching Health Centers, advocate for introduction of bipartisan bill to reauthorize the program. No Bill Number, FY funding increses in AHRQ, Title VII 747, NHSC, Teaching Health Center planning grants, Federal spending priorities to support workforce, research. No Bill Number, Veterans Health Care, advocate for inclusion of policies in final bill that allow family doctors to easily contract with the VA; advocate for primary-care GME slots in the VA. No Bill Number, FDA regulation of tobacco products, Oppose any limits or amendments that would limit FDA ability to regulate cigars. No Bill Number, E-Cigarettes impact on public health; Support FDA regulation of e-cigarettes, still urging FDA to regulate all tobacco. No Bill Number, National Health Service Corps trust fund reauthorization, appropriation, NHSC provides scholarships & debt relief as well as physicians for underserved communities.No Bill Number, Rural workforce, Comments on FQHC final rule. No Bill Number, VA committee on Woman Veterans, Nominated to FPs to the VA committee. No Bill Number, HHS Appropriations, Funding for health professions training grants, AHRQ research, and National Health Service Corps (NHSC). No Bill Number, Enhanced Medicaid payment for primary care, Extending the enhanced Medicaid payment for primary care. No Bill Number, Site-neutral payment for medical services, Support site-neutral payment by CMS for medical services. No Bill Number, White House's Health Kids and Save Sports Concussion Summit, Providing family physicians with latest information about sports concussions. No Bill Number, Veterans Health Administration, Allowing community physicians to charge VA for services to Vets. No Bill Number, Direct Primary Care, Primary care model of retainer-based practice. No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, 2014 conversion factor. No Bill Number, Graduate Medical Education, comments on 2015 proposed IPPS. No Bill Number, Health IT, asking CMS to delay MU2. No Bill Number, Non-discrimination, Advocate for correct use of non-discrimination clause in Affordable Care Act. No Bill Number, Extend Medicare/Medicare parity for primary services, extend Medicaid pay increase to Medicare levels beyond 2015. No Bill Number, First Fridays Meetings, Provider outreach group for Affordable Care Act, provider and open enrollment issues.
Client expense: $1,257,519 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · first_quarter · Health Issues
HR 487, Primary Care Workforce Access Improvement Act, Urge House to cosponsor bill that would create GME pilot project to train primary care doctors, urge Senate offices to sponsor bill, GME reform increase primary care physician training, Pilot test alternatives to GME payment in order to increase primary care physician training.HR 2415, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. HR 3306, Telehealth Enhancement Act, Defining the home base for telehealth reimbursement to incluse family medicine offices. HR 4299, Improving Regulatory Transparency for New Medical Therapies Act, Improving DEA's process for scheduling new drugs approved by the FDA. HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act, Allowing supply chain stakeholders for prescription drugs to collaborate. HR 4810, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside. S. 1184, Treat and Reduce Obsity, Seeking House and Senate cosponsors for obesity legislation. S. 1759, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program. S. 1994, TRICARE Moms Improvement Act, Supporting TRICARE payment for breastfeeding support and supplies and counseling. S. 1978, Increasing Primary Care Access Act, Family physician workforce, Teaching Health Center Reauthorization Act, Reauthorize the Teaching Health Centers Graduate Medical Education program, increase family physician workforce. S. 2229, Expanding Primary Care Access and Workforce Act, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC, Reauthorizing Teaching Health Center GME program, Teaching Health Centers Graduate Medical Education, Reauthorizing Title VII primary care programs, Teaching Health Centers and the NHSC. S. 2450, VA Health Reform, Improve access for veterans to primary care services, both inside the VA and outside No Bill Number, Extend Medicare/Medicare parity for primary care services, Extend Medicaid pay increase to Medicare levels beyond 2015. H. Con. Res. 96, House Budget Resolution, Protecting access to primary care in Medicaid. No Bill Number, Children's Health, Advocate for reauthorization of CHIP and children's mental health issues via coalition group meetings. No Bill Number, First Friday & Health Care Provider Meetings, Provider outreach groups for ACA, provider, and open enrollment issues. No Bill Number, SGR Repeal and Replacement process, Advocate for SGR repeal and new physician payment system that pays for value and primary care. No Bill Number, Medicaid Primary Care Bonus, Advocate for extension of the Medicaid bonus which expires at the end of 2014; advocate for members to mention at E&C hearing. No Bill Number, Medicare Primary Care Incentive Payment, Urge Ways and Means members to discuss at annual MedPac hearing. No Bill Number, Telemedicine,advocate for AAFP policies to be included in a potential bipartisan telehealth bill. No Bill Number, Teaching Health Centers, advocate for introduction of bipartisan bill to reauthorize the program. No Bill Number, FY funding increses in AHRQ, Title VII 747, NHSC, Teaching Health Center planning grants, Federal spending priorities to support workforce, research. No Bill Number, Veterans Health Care, advocate for inclusion of policies in final bill that allow family doctors to easily contract with the VA; advocate for primary-care GME slots in the VA. No Bill Number, FDA regulation of tobacco products, Oppose any limits or amendments that would limit FDA ability to regulate cigars. No Bill Number, E-Cigarettes impact on public health; Support FDA regulation of e-cigarettes, still urging FDA to regulate all tobacco. No Bill Number, National Health Service Corps trust fund reauthorization, appropriation, NHSC provides scholarships & debt relief as well as physicians for underserved communities.No Bill Number, Rural workforce, Comments on FQHC final rule. No Bill Number, VA committee on Woman Veterans, Nominated to FPs to the VA committee. No Bill Number, HHS Appropriations, Funding for health professions training grants, AHRQ research, and National Health Service Corps (NHSC). No Bill Number, Enhanced Medicaid payment for primary care, Extending the enhanced Medicaid payment for primary care. No Bill Number, Site-neutral payment for medical services, Support site-neutral payment by CMS for medical services. No Bill Number, White House's Health Kids and Save Sports Concussion Summit, Providing family physicians with latest information about sports concussions. No Bill Number, Veterans Health Administration, Allowing community physicians to charge VA for services to Vets. No Bill Number, Direct Primary Care, Primary care model of retainer-based practice. No Bill Number, Medicare physician payment reform of the Sustainable Growth Rate, 2014 conversion factor. No Bill Number, Graduate Medical Education, comments on 2015 proposed IPPS. No Bill Number, Health IT, asking CMS to delay MU2. No Bill Number, Non-discrimination, Advocate for correct use of non-discrimination clause in Affordable Care Act. No Bill Number, Extend Medicare/Medicare parity for primary services, extend Medicaid pay increase to Medicare levels beyond 2015. No Bill Number, First Fridays Meetings, Provider outreach group for Affordable Care Act, provider and open enrollment issues.
Client expense: $1,257,519 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, Veterans Affairs, Dept of (VA)
2014 · second_quarter · Health Issues
Efforts to prevent prescription drug abuse, H.R. 4709- The Ensuring Patient Access and Effective Drug Enforcement Act of 2014
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014"
Client expense: $250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Pharmacy
H.R.800 & S.806 (Medicare Prompt Pay Discount Exclusion), legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R.1416 (Cancer Patient Protection Act of 2013) legislation to exclude cancer drugs from sequestration cuts. H.R.4709, S.1277, S.1657, H.R.3392 & H.R.4096 legislation to prevent and reduce prescription drug abuse.H.R. 4190, Provide for coverage under Medicare program of pharmicist services
Client expense: $350,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2014 · second_quarter · Pharmacy
Pharmacy issues, prescription drug supply chain issues, drug shortages, prescription drug abuse and diversion. H.R.4709 "Ensuring Patient Access and Effective Drug Enforcement Act of 2014"
Client expense: Not reported · Firm income: $60,000
Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2014 · second_quarter · Medicare/Medicaid
Implementation of the Patient Protection and Affordable Care Act; issues related to Medicare drug reimbursement; H.R. 8; H.R. 800; S. 806; H.R.1416; H.R. 4709
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE